From Jurassic Park to the cutting edge of mRNA innovation: the story of Dr. Pooja Tiwari

Recently on the Biotech and Life Science CEO’s podcast, we’ve been talking about the speed at which change is occurring in the life sciences. And nowhere is that clearer than in the field of mRNA. By now everyone must know that the COVID vaccines were created literally days after the genome of the virus had been sequenced. But I don’t think we’ve still processed what that really means. Our guest today is Dr. Pooja Tiwari, the founder of Arnav Biotech, dedicated to the design and manufacture of both custom and cataloged mRNA for use in therapeutic vaccine, diagnostic, and even agricultural applications. Disclaimer The information contained in this website and podcast are purely informational and not considered investment recommendations.  Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor representative. Nothing contained herein may be construed as a recommendation or endorsement of any of the companies discussed. Tim Dougherty has no financial affiliation with any of the companies mentioned in this communication. Tim Dougherty makes no representation that the information conveyed in this material is accurate and is under no obligation to update this information as changes occur.